小儿过敏性鼻炎中医治疗临床实践指南

2021-07-29 中医相关专家组(统称) Anat Rec (Hoboken) . 2021 Jul 29

过敏性鼻炎(AR)是儿童最常见的过敏性疾病之一,它可以导致身体和精神健康问题。中医在了解过敏性鼻炎的表型和治疗方面发挥着重要作用。然而,目前还没有治疗儿童AR的规范性临床实践指南(CPGs)。本研究旨

中文标题:

小儿过敏性鼻炎中医治疗临床实践指南

英文标题:

Clinical practice guidelines for the treatment of allergic rhinitis in children with traditional Chinese medicine

发布日期:

2021-07-29

简要介绍:

过敏性鼻炎(AR)是儿童最常见的过敏性疾病之一,它可以导致身体和精神健康问题。中医在了解过敏性鼻炎的表型和治疗方面发挥着重要作用。然而,目前还没有治疗儿童AR的规范性临床实践指南(CPGs)。本研究旨在为中医治疗儿童AR制定一个基于证据的CPG。采用系统的文献研究、专家问卷调查和三轮调查后的临床评价,用德尔菲法形成治疗儿童AR的建议。根据临床表现,我们最终推荐了两味中成药煎煮治疗AR的急性发作期和两味煎煮治疗AR的慢性期。对于儿童急性发作期的AR,建议使用信谊清瘟汤、温补志略汤、心清颗粒、信谊碧岩丸;而对于慢性期的AR,建议使用布中益气汤和金匮肾气汤。建议用于预防和护理AR的四种外部治疗方法是体针、艾灸、耳穴按压和穴位应用。建议的中医策略的推荐等级从B级到D级不等,说明建议的力度不大。中医有可能为世界范围内的AR表型和管理提供新的见解;然而,需要更多高质量的临床研究来提高证据的质量。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=小儿过敏性鼻炎中医治疗临床实践指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c94a91c0021a36b9, title=小儿过敏性鼻炎中医治疗临床实践指南, enTitle=Clinical practice guidelines for the treatment of allergic rhinitis in children with traditional Chinese medicine, guiderFrom=Anat Rec (Hoboken) . 2021 Jul 29, authorId=0, author=, summary=过敏性鼻炎(AR)是儿童最常见的过敏性疾病之一,它可以导致身体和精神健康问题。中医在了解过敏性鼻炎的表型和治疗方面发挥着重要作用。然而,目前还没有治疗儿童AR的规范性临床实践指南(CPGs)。本研究旨, cover=https://img.medsci.cn/2021731/1627742746513_2020535.jpg, journalId=0, articlesId=null, associationId=1108, associationName=中医相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Thu Jul 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p>过敏性鼻炎(AR)是儿童最常见的过敏性疾病之一,它可以导致身体和精神健康问题。中医在了解过敏性鼻炎的表型和治疗方面发挥着重要作用。然而,目前还没有治疗儿童AR的规范性临床实践指南(CPGs)。本研究旨在为中医治疗儿童AR制定一个基于证据的CPG。采用系统的文献研究、专家问卷调查和三轮调查后的临床评价,用德尔菲法形成治疗儿童AR的建议。根据临床表现,我们最终推荐了两味中成药煎煮治疗AR的急性发作期和两味煎煮治疗AR的慢性期。对于儿童急性发作期的AR,建议使用信谊清瘟汤、温补志略汤、心清颗粒、信谊碧岩丸;而对于慢性期的AR,建议使用布中益气汤和金匮肾气汤。建议用于预防和护理AR的四种外部治疗方法是体针、艾灸、耳穴按压和穴位应用。建议的中医策略的推荐等级从B级到D级不等,说明建议的力度不大。中医有可能为世界范围内的AR表型和管理提供新的见解;然而,需要更多高质量的临床研究来提高证据的质量。</p> <p>&nbsp;</p>, tagList=[TagDto(tagId=9982, tagName=过敏性鼻炎)], categoryList=[CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=9982, guiderKeyword=过敏性鼻炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9812, appHits=263, showAppHits=0, pcHits=823, showPcHits=9545, likes=0, shares=16, comments=7, approvalStatus=1, publishedTime=Sat Jul 31 22:51:53 CST 2021, publishedTimeString=2021-07-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 31 22:45:56 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 15:59:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=小儿过敏性鼻炎中医治疗临床实践指南.pdf)])
小儿过敏性鼻炎中医治疗临床实践指南.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191187, encodeId=fc5f119118efb, content=写得非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 20:38:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070396, encodeId=8ac510e0396e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87994738610, createdName=411184578, createdTime=Mon Nov 15 12:55:00 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067118, encodeId=7ce4106e118e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e85f5623323, createdName=ms6000000669218742, createdTime=Fri Nov 05 01:23:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066095, encodeId=68241066095c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Tue Nov 02 07:07:01 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060440, encodeId=6d6d1060440e9, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff1f5635321, createdName=ms7000001955151128, createdTime=Thu Oct 14 13:14:21 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2022-02-08 ms3000000637975859

    写得非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191187, encodeId=fc5f119118efb, content=写得非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 20:38:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070396, encodeId=8ac510e0396e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87994738610, createdName=411184578, createdTime=Mon Nov 15 12:55:00 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067118, encodeId=7ce4106e118e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e85f5623323, createdName=ms6000000669218742, createdTime=Fri Nov 05 01:23:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066095, encodeId=68241066095c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Tue Nov 02 07:07:01 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060440, encodeId=6d6d1060440e9, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff1f5635321, createdName=ms7000001955151128, createdTime=Thu Oct 14 13:14:21 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-11-15 411184578

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191187, encodeId=fc5f119118efb, content=写得非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 20:38:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070396, encodeId=8ac510e0396e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87994738610, createdName=411184578, createdTime=Mon Nov 15 12:55:00 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067118, encodeId=7ce4106e118e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e85f5623323, createdName=ms6000000669218742, createdTime=Fri Nov 05 01:23:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066095, encodeId=68241066095c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Tue Nov 02 07:07:01 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060440, encodeId=6d6d1060440e9, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff1f5635321, createdName=ms7000001955151128, createdTime=Thu Oct 14 13:14:21 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-11-05 ms6000000669218742

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191187, encodeId=fc5f119118efb, content=写得非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 20:38:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070396, encodeId=8ac510e0396e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87994738610, createdName=411184578, createdTime=Mon Nov 15 12:55:00 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067118, encodeId=7ce4106e118e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e85f5623323, createdName=ms6000000669218742, createdTime=Fri Nov 05 01:23:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066095, encodeId=68241066095c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Tue Nov 02 07:07:01 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060440, encodeId=6d6d1060440e9, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff1f5635321, createdName=ms7000001955151128, createdTime=Thu Oct 14 13:14:21 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-11-02 小白努力长高高

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191187, encodeId=fc5f119118efb, content=写得非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 20:38:52 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070396, encodeId=8ac510e0396e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87994738610, createdName=411184578, createdTime=Mon Nov 15 12:55:00 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067118, encodeId=7ce4106e118e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e85f5623323, createdName=ms6000000669218742, createdTime=Fri Nov 05 01:23:21 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1066095, encodeId=68241066095c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65aa5643711, createdName=小白努力长高高, createdTime=Tue Nov 02 07:07:01 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060440, encodeId=6d6d1060440e9, content=不错哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff1f5635321, createdName=ms7000001955151128, createdTime=Thu Oct 14 13:14:21 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-14 ms7000001955151128

    不错哦

    0

拓展阅读

2017 JSA指南:过敏性鼻炎

日本变态反应学会(JSA,Japanese Society of Allergology) · 2017-02-14

中国过敏性鼻炎诊治指南(英文版)

中华医学会变态反应学分会 · 2018-06-20

2022 MSAI共识声明:过敏性鼻炎的药物治疗

马来西亚胃肠病、肝病学会(MSGH,Malaysian Society of Gastroenterology &amp; Hepatology) · 2022-08-02

2022 药房袖珍指南:过敏性鼻炎症状的管理

欧洲过敏学和临床免疫学学会 (EAACI) · 2022-10-05